Krane Funds Advisors LLC Legend Biotech Corp Transaction History
Krane Funds Advisors LLC
- $2.45 Billion
- Q3 2024
A detailed history of Krane Funds Advisors LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Krane Funds Advisors LLC holds 18,780 shares of LEGN stock, worth $715,518. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,780
Previous 915
1952.46%
Holding current value
$715,518
Previous $44,000
1979.55%
% of portfolio
0.04%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.6MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$425 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$286 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$253 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$218 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$192 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.38B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...